WNT5A and atherosclerosis: When the level of SFRP5 is increased, it can reduce the proliferation and differentiation of cardiac fibroblasts by regulating Wnt5a protein, accelerate the activation of cytokines, inhibit the activation of macrophages in adipose tissue, suppress the release of inflammatory cells, and reduce the degree of atherosclerosis to prevent ISR [14].